DelveInsight's Influenza Vaccine Market Insights report provides the current and forecast market analysis, individual leading influenza vaccine companies' market shares, challenges, influenza vaccine ...

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.

Seasonal flu vaccines need to be updated each year because the virus changes so frequently. But the U.S. hasn't contributed ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

This little-known artificial intelligence growth stock is backed by chipmaker Nvidia and recently jumped nearly 24% in a ...

Kelso Pharma, the British specialty pharma business backed by Apposite Capital, today announced the acquisition of the UK ...

Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...

Sanofi and CD&R sign Opella share purchase agreement Paris, February 19, 2025. Following completion of the required social and corporate procedures, Sanofi and CD&R announce today they have signed the ...

Advances in technology, especially AI, are making it easier to deliver personalised experiences. AI can analyse vast amounts ...

Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold ...

Advisers scored lucrative roles on deals in 2024 including Sanofi’s consumer healthcare sale and the take-private of UK cyber ...